Nanomedicine And veterinary Treatment | ||||
| Translational Health Sciences | ||||
| Volume 1, Issue 2, August 2025, Page 69-85 PDF (502.21 K) | ||||
| Document Type: Review Article | ||||
| DOI: 10.21608/ths.2025.410024.1011 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Marwa Mahmoud Fawzy  
| ||||
| Veterinary Medicine, Egyptian Chinese University, Egypt | ||||
| Abstract | ||||
| In recent decades, the concept of nanomedicine has undergone a significant transformation, utilizing the distinctive phenomenon known as the enhanced permeability and retention effect. By incorporating nanotechnology principles into medicine, this has enabled significant progress in individualized therapy, imaging, and targeted drug delivery. The treatment of diseases has been the focus of the development and application of numerous nanomedicines, with a particular emphasis on cancer therapy. Recently, nanomedicine has been employed in a variety of advanced disciplines, such as gene delivery, tissue engineering, immunotherapy, vaccines, and diagnosis. Moreover, nanomedicine has shown immense promise in treating complex conditions such as cardiovascular disease (CVD), diabetes, kidney cancer, and neurological disorders. Multifunctional nanomedicines enable the administration of medication, therapeutic monitoring, and imaging simultaneously, thereby enabling the development of personalized treatment plans and immediate responses. Beyond treatment, nanomedicine contributes to advanced diagnostics, tissue regeneration, antibacterial applications, and non-viral gene delivery. These benefits mark a significant step toward personalized and predictive medicine. Despite its immense promise, nanomedicine still faces challenges such as manufacturing scalability, limited targeting efficiency, safety concerns, and regulatory complexities. Therefore, this review article aimed to explore the latest advancements in nanomedicine for disease treatment, highlighting key innovations in nanoparticle design, therapeutic applications, and clinical translation challenges. We discussed in this review how nanomedicine is reshaping modern therapeutics and identified future directions for overcoming remaining barriers in this rapidly evolving field. | ||||
| Keywords | ||||
| Nanomedicine; Tissue engineering; Gene therapy; Cancer; cardiovascular disease | ||||
|
Statistics Article View: 8 PDF Download: 3 |
||||
